title: Danazol-induced hepatocellular carcinoma.
authors.forename: C
authors.initials: C
authors.lastname: Confavreux
authors.forename: P
authors.initials: P
authors.lastname: Sève
authors.forename: C
authors.initials: C
authors.lastname: Broussolle
authors.forename: P
authors.initials: P
authors.lastname: Renaudier
authors.forename: C
authors.initials: C
authors.lastname: Ducerf
mesh_terms: D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced* / Q000150:complications; D003613:Danazol / Q000009:adverse effects*; D004965:Estrogen Antagonists / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000150:complications; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications / Q000188:drug therapy
chemical_list: D004965:Estrogen Antagonists; D003613:Danazol